At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

Meaning, whether you lose weight through a change in your diet, a different medication, or bariatric surgery, there is a risk ...

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...